Bausch Health Companies Inc. Excess Tax Benefit from Share-based Compensation, Operating Activities
Bausch Health Companies Inc. (BHC) reported Excess Tax Benefit from Share-based Compensation, Operating Activities of -$3.90 million for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-10-26.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2015-10-26
- Bausch Health Companies Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-09-30 was -$3.90M, a 124.53% decline year-over-year.
- Bausch Health Companies Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-06-30 was $7.70M.
- Bausch Health Companies Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-03-31 was $17.90M, a 1391.67% increase year-over-year.
- Bausch Health Companies Inc. excess tax benefit from share-based compensation, operating activities for the quarter ending 2014-09-30 was $15.90M, a 50.62% decline year-over-year.
- Bausch Health Companies Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2012 was $12.54M, a 52.73% decline from fiscal 2011.
- Bausch Health Companies Inc. excess tax benefit from share-based compensation, operating activities for fiscal 2011 was $26.53M.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month as first filed | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month as first filed | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month as first filed | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2015-09-30 | -$3.90M 10-Q · filed 2015-10-26 | $3.80M derived: sum of 2 quarters · filed 2015-10-26 | $21.70M 10-Q · filed 2015-10-26 | ||||
| 2015-06-30 | $7.70M 10-Q · filed 2015-07-28 | $25.60M 10-Q · filed 2015-07-28 | |||||
| 2015-03-31 | $17.90M 10-Q · filed 2015-04-30 | ||||||
| 2014-09-30 | $15.90M 10-Q · filed 2015-10-26 | $15.90M derived: sum of 2 quarters · filed 2015-10-26 | $17.10M 10-Q · filed 2015-10-26 | ||||
| 2014-06-30 | $0.00 10-Q · filed 2015-07-28 | $1.20M 10-Q · filed 2015-07-28 | |||||
| 2014-03-31 | $1.20M 10-Q · filed 2015-04-30 | ||||||
| 2013-09-30 | $32.20M 10-Q · filed 2014-10-24 | $32.18M 10-Q · filed 2013-11-01 | $44.00M derived: sum of 2 quarters · filed 2014-10-24 | $48.60M 10-Q · filed 2014-10-24 | $48.63M 10-Q · filed 2013-11-01 | $55.30M derived: sum of 4 quarters · filed 2014-10-24 | |
| 2013-06-30 | $11.80M 10-Q · filed 2014-08-01 | $11.85M 10-Q · filed 2013-08-07 | $16.40M 10-Q · filed 2014-08-01 | $16.45M 10-Q · filed 2013-08-07 | $23.10M derived: sum of 3 quarters · filed 2014-08-01 | $25.47M derived: sum of 4 quarters · filed 2014-08-01 | |
| 2013-03-31 | $4.60M 10-Q · filed 2014-05-09 | $4.60M 10-Q · filed 2013-05-03 | $11.30M derived: sum of 2 quarters · filed 2014-05-09 | $13.67M derived: sum of 3 quarters · filed 2014-05-09 | $16.55M derived: sum of 4 quarters · filed 2014-05-09 | ||
| 2012-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $9.07M derived: sum of 2 quarters · filed 2013-11-01 | $11.95M derived: sum of 3 quarters · filed 2013-11-01 | $12.54M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $2.37M 10-Q · filed 2013-11-01 | $5.25M derived: sum of 2 quarters · filed 2013-11-01 | $5.84M 10-Q · filed 2013-11-01 | -$1.28M derived: sum of 4 quarters · filed 2013-11-01 | |||
| 2012-06-30 | $2.88M 10-Q · filed 2013-08-07 | $3.48M 10-Q · filed 2013-08-07 | -$3.65M derived: sum of 3 quarters · filed 2013-08-07 | -$1.61M derived: sum of 4 quarters · filed 2013-08-07 | |||
| 2012-03-31 | $593.00K 10-Q · filed 2013-05-03 | -$6.53M derived: sum of 2 quarters · filed 2013-05-03 | -$4.49M derived: sum of 3 quarters · filed 2013-05-03 | $3.08M derived: sum of 4 quarters · filed 2013-05-03 | |||
| 2011-12-31 | -$7.13M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$5.08M derived: sum of 2 quarters · filed 2013-02-28 | $2.48M derived: sum of 3 quarters · filed 2013-02-28 | $26.53M 10-K · filed 2013-02-28 | |||
| 2011-09-30 | $2.04M 10-Q · filed 2012-11-05 | $9.61M derived: sum of 2 quarters · filed 2012-11-05 | $33.66M 10-Q · filed 2012-11-05 | ||||
| 2011-06-30 | $7.57M 10-Q · filed 2012-08-03 | $31.62M 10-Q · filed 2012-08-03 | |||||
| 2011-03-31 | $24.05M 10-Q · filed 2012-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |